Insider · CIK 0002050984
Juho Sarvikas
ceoofficerdirector
Files at INSG (INSEEGO CORP.). First filing Mar 5, 2025, latest Mar 5, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$98k bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
INSG: INSEEGO CORP.
INSGOct 9, 2026 · close 4.58
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | INSG INSEEGO CORP. | POpen-market purchase Common Stock | +10,000 | $9.78 | $98k | 134,347 | Mar 5, 2025 |
| Jan 6, 2025 | INSG INSEEGO CORP. | AGrant or award Common Stock | +124,347 | $0.00 | $0 | 123,347 | Jan 7, 2025 |
| Jan 6, 2025 | INSG INSEEGO CORP. | AGrant or award Stock Options (right to buy)derivative | +200,000 | $0.00 | $0 | 200,000 | Jan 7, 2025 |
| Jan 6, 2025 | INSG INSEEGO CORP. | AGrant or award Stock Options (right to buy)derivative | +210,000 | $0.00 | $0 | 210,000 | Jan 7, 2025 |
| Jan 6, 2025 | INSG INSEEGO CORP. | AGrant or award Stock Options (right to buy)derivative | +215,000 | $0.00 | $0 | 215,000 | Jan 7, 2025 |
| Jan 6, 2025 | INSG INSEEGO CORP. | AGrant or award Stock Options (right to buy)derivative | +225,000 | $0.00 | $0 | 225,000 | Jan 7, 2025 |
| Jan 6, 2025 | INSG INSEEGO CORP. | AGrant or award Performance Share Unitsderivative | +167,910 | $0.00 | $0 | 167,910 | Jan 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.